Neovascular glaucoma: A historical perspective on modulating angiogenesis

Seminars in Ophthalmology

Volumn 24, Issue 2, 2009, Pages 106-112

  Anchala, Anupama R ^a   Pasquale, Louis R ^a  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; FLUOROURACIL; MITOMYCIN C; RANIBIZUMAB; VASCULOTROPIN ANTIBODY; ANGIOGENESIS MODULATOR;

ANGIOGENESIS; CLINICAL FEATURE; DIATHERMY; DISEASE COURSE; GONIOSCOPY; HUMAN; INTRAOCULAR PRESSURE; LASER COAGULATION; NEOVASCULAR GLAUCOMA; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA ISCHEMIA; RETINA NEOVASCULARIZATION; REVIEW; TRABECULECTOMY; TREATMENT RESPONSE; VITRECTOMY; ARTICLE; HISTORY; OPHTHALMOLOGY;

ANGIOGENESIS MODULATING AGENTS; GLAUCOMA, NEOVASCULAR; HISTORY, 20TH CENTURY; HUMANS; OPHTHALMOLOGY;

EID: 66149118657     PISSN: 08820538     EISSN: 17445205     Source Type: Journal    
DOI: 10.1080/08820530902800959     Document Type: Review

References (38)

1. Sivak-Callcott JA, O'Day DM, Gass JDM, Tsai JC. Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma. Ophthalmology 2001;108:1767-1776.
2. Bushmann I, Schaper W. Arteriogenesis vs. angiogenesis: Two mechanisms of vessel growth. News Physiol Sci 1999;14:121-125.
3. Duke-Elder S, ed. System of Ophthalmology, Vol XI: Diseases of the Lens and Vitreous, Glaucoma and Hypotony. St Louis: C.V. Mosby, 1969; chapter 9.
4. Cairns JE. Rationale for therapy in neovascular glaucoma. Trans Ophthalmol Soc U K 1981;184-185.
5. Michaelson IC. The mode of development of the vascular system of the retina, with some observations on its significance for certain retinal diseases. Trans Ophthalmol Soc U K 1948;68:137- 180.
6. Folkman J. Tumor angiogenesis: Therapeutic implications. N Engl J Med 1971;285:1182-1186.
7. Brown GC, Magargal LE, Schachat A, Shah H. Neovascular glaucoma. Etiologic considerations. Ophthalmology 1984;91:115-120.
8. Fanous MM. Neovascular Glaucoma. Albert and Jakobiec. Chapter 225. Boston, MA, 2009.
9. Hayreh SS. Neovascular glaucoma. Progress in Retinal and Eye Research 2007;26:470-485.
10. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994;331:1480- 1487.
11. Adamis AP, Miller JW, Bernal MT, et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 1994;118:445-450.
12. Adamis AP, Miller JW, O'Reilly M, et al. Vascular permeability factor (vascular endothelial growth factor) is produced in the retina and elevated levels are present in the aqueous humor of eyes with iris neovascularization. Invest Ophthalmol Vis Sci 1993;34:1440. Abstract.
13. Casey R, Li WW. Factors controlling ocular angiogenesis. Am J Ophthalmol 1997;124:521-529.
14. Chen KH, Wu CC, Roy S, et al. Increased interleukin-6 in aqueous humor of neovacular glaucoma. Invest Ophthalmol Vis Sci 1999;40:2627-2632.
15. Browning DJ, Scott AQ, Peterson CB, et al. The risk of missing angle neovascularization by omitting screening go-nioscopy in acute central retinal vein occlusion. Ophthalmology 1998;105:776-784.
16. Ohnishi Y, Ishibashi T, Sagawa T. Fluorescein gonioangiogra-phy in diabetic neovascularization. Graefes Arch Clin Exp Ophthalmol 1994;232:199-204.
17. John T, Sassani JW, Eagle RC Jr. The myofibroblastic component of rubeosis iridis. Ophthalmology 1983;90:721-728.
18. AielloLM, WandM,LiangG.Neovascularglaucomaandvitre-ous hemorrhage after cataract surgery in patients with diabetes mellitus. Ophthalmology 1983;90:814-820.
19. Magargal LE, Brown GC, Augsburger JJ, Donoso LA. Efficacy of panretinal photocoagulation in preventing neovascular glaucoma following ischemic central retinal vein obstruction. Ophthalmology 1982;89:780-784.
20. Pavan PR, Folk JC, Weingist TA, et al. Diabetic rubeosis and panretinal photocoagulation. A prospective, controlled, masked trial using iris fluorescein angiography. Arch Ophthlmol 1983;01:882-884.
21. Wand M, Dueker DK, Aiello LM, Grant WM. Effects of argon laser photocoagulation on rubeosis iridis, angle neo- vascularization and neovascular glauoma. Am J Ophthalmol 1978;86:332-339.
22. Little HL, Rosenthal AR, Dellaporta A, Jacobson DR. The effect of panretinal photocoagulation on rubeosis iridis. Am J Ophthamol 1976;81:804-809.
23. Baseline and early natural history report. The Central Vein Occlusion Study. Central Vein Occlusion Study Group. Arch Ophthalmol 1993;11:1087-1095.
24. Allen RC, Bellows AR, Hutchinson BT, Murphy SD. Filtration surgery in the treatment of neovascular glaucoma. Ophthalmology 1982;89:1181-1187.
25. Tsai JC, Feuer WJ, Parrish RK II, Grajewski AL. 5-Fluorouracil filtering surgery and neovascular glaucoma. Long-term follow-up of the original pilot study. Ophthalmology 1995;102:887- 892.
26. Ruderman JM, Welch DB, Smith MF, Shoch DE. A randomized study of 5-Fluorouracil and filtration surgery. Am J Ophthalmol 1987;104:218-224.
27. Katz GJ, Higginbotham EJ, Lichter PR, et al. Mitomycin C versus 5-Fluorouracil in high-risk glaucoma filtering surgery. Extended follow-up. Ophthalmology 1995;102:1263-1269.
28. Sidoti PA, Dunphy TR, Baerveldt G, et al. Experience with the Baerveldt glaucoma implant in treating neovascular glaucoma. Ophthalmology 1995;102:1107-1118.
29. Mermoud A, Salmon JF, Aexander P, et al. Molteno tube implantation for neovascular glaucoma. Long-term results and factors influencing the outcome. Ophthalmology 1993;100:897- 902.
30. Krupin T, Kauffman P, Mandell AI, et al. Long-term results of valve implants in filtering surgery for eyes with neovascular glaucoma. Am J Ophthalmol 1983;95:775-782.
31. Scott IU, Alexandrakis G, Flynn HW Jr, et al. Combined pars plana vitrectomy and glaucoma drainage implant placement for refractory glaucoma. Am J Ophthamol 2000;129:334- 341.
32. Luttrull JK, Avery RL. Pars plana implant and vitrectomy for treatment of neovascular glaucoma. Retina 1995;15:379-387.
33. Avery RL, Pearlman J, Pieramici DJ, et al. Intravitreal beva-cizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthamology 2006;113:1695-1705.
34. Wakabayashi T, Oshima Y, Sakaguchi H, et al. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases. Ophthalmology 2008;115:1571-1580.
35. Beutel J, Peters S, Luke M, et al. Bevacizumab as adjuvant for neovascular glaucoma. Acta Ophthalmologica 2008 1-7.
36. Davidorf FH, Mouser JG, Derick RJ. Rapid improvement of rubeosis iridis from a single bevacizumab (Avastin) injection. Retina 2006;26:354-356.
37. Andreoli CM, Miller JW. Anti-vascular endothelial growth factor therapy for ocular neovascular disease. Curr Opin Ophthalmol 2007;18:502-508.
38. Aiello LM, Beetham WP, Balodimos MC, et al. Ruby laser photocoagulation and treatment of diabetic proliferating retinopathy. In Goldberg MF, Fine SL (eds.): Symposium on the Treatment of Diabetic Retinopathy. Washington, DC: U.S. Public Health Service, 1969;1890:437.